跳至主要内容
临床试验/NCT04616261
NCT04616261Unknown不适用

Trainability of the beta2-adrenergic System With Respect to Performance

University of Copenhagen0 个研究点目标入组 30 人开始时间: 2020年11月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
30
主要终点
Sprint performance

研究概览

简要总结

This project aims to examine the trainability of the beta2-adrenergic system with respect to the individual performance response

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 18 to 45 years of age
  • Trained individuals with a maximal oxygen uptake above 55 ml/min/kg
  • Body mass index lower than 26

排除标准

  • Allergy towards study drug
  • Unacceptable side effects to the study drug
  • Chronic disease deemed by the MD to interfere with the study
  • Use of prescription medicine

研究组 & 干预措施

SET-HIGH

Experimental

High volume speed endurance training

干预措施: Training (Behavioral)

SET-HIGH

Experimental

High volume speed endurance training

干预措施: Formoterol (Drug)

SET-HIGH

Experimental

High volume speed endurance training

干预措施: Placebo (Drug)

SET-LOW

Experimental

Low volume speed endurance training

干预措施: Training (Behavioral)

SET-LOW

Experimental

Low volume speed endurance training

干预措施: Formoterol (Drug)

SET-LOW

Experimental

Low volume speed endurance training

干预措施: Placebo (Drug)

结局指标

主要结局

Sprint performance

时间窗: ½ hour after administration of formoterol or placebo

Change in power output during maximal cycling in response to formoterol

次要结局

  • Cycling endurance performance(½ hour after administration of formoterol or placebo)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Morten Hostrup, PhD

Associate Professor

University of Copenhagen

相似试验